Moreover, CsA was shown to inhibit the growth of both androgen-sensitive and androgen receptor (AR)-negative prostate cancer lines, while FK506 inhibited only AR-dependent growth but failed to do in AR-negative cells [25]. This evidence concerns the gene AR and prostate carcinoma.